{"product_id":"brain-energy-metabolism-alzheimers-c","title":"Brain Energy Metabolism in Alzheimer's Disease – Part C, Volume 188","description":"\u003ch3\u003e\u003cstrong\u003eEditor: Subashchandrabose Chinnathambi\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eISBN:\u003c\/strong\u003e 9780443345258\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePublished:\u003c\/strong\u003e August 2026\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eFormat:\u003c\/strong\u003e Softcover\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLanguage:\u003c\/strong\u003e English\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePublisher:\u003c\/strong\u003e Elsevier (International Review of Neurobiology, Volume 188)\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eDescription\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003e\u003cem\u003eBrain Energy Metabolism in Alzheimer's Disease – Part C\u003c\/em\u003e, Volume 188 in the \u003cem\u003eInternational Review of Neurobiology\u003c\/em\u003e series, presents the latest research on metabolic dysfunction and its role in neurodegenerative diseases. This volume brings together contributions from an international panel of experts, exploring the molecular, cellular, and systemic aspects of energy metabolism in Alzheimer's disease and related disorders.\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eKey Features\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003ePresents current advances in brain energy metabolism and neurodegenerative disease research, with contributions from leading experts in neuroscience, neurobiology, and metabolic research. Covers molecular, cellular, and systemic aspects of metabolic dysfunction in Alzheimer's disease, and explores therapeutic targets, diagnostic approaches, and emerging treatment strategies including nanocarrier-based therapies and HDAC inhibitors.\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eCoverage\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eFifteen chapters examining metabolic therapeutic targets in Alzheimer's disease, brain energy metabolism changes compared with Parkinson's disease, epigenetic modulation via natural compounds, mitochondrial vulnerability and lactate shuttle disruption, astroglial dysregulation in schizophrenia, metabolic disorders and Parkinson's disease, PPAR-γ signalling in ALS and Huntington's disease, cholinesterase-targeting therapeutics, intestinal microbiota in neurodegeneration, nanocarrier-based therapeutic breakthroughs, HDAC inhibitors, the tau-mitochondria connection, brain lipid dysregulation, and mechanisms, markers and therapeutic prospects in metabolic dysregulation.\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eAbout the Editor\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eSubashchandrabose Chinnathambi\u003c\/strong\u003e is Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, Karnataka, India. His scientific interests include physiopathology of neurodegenerative disorders, Tau cytoskeleton, Tau-GPCR, purinergic and chemokine receptors, Tau stem cells, animal models, neuropharmacology, and therapeutic approaches targeting Tau oligomers and biomarkers for neurodegeneration. He has more than 16 years of research experience in neuroscience and Tau-related research in Alzheimer's disease.\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eTable of Contents\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003e1. Metabolic Therapeutic Targets in Alzheimer's Disease (AD)\u003cbr\u003e2. Brain Energy Metabolism Changes and Neuropsychological Impairment in Parkinson Disease vs Alzheimer's Disease\u003cbr\u003e3. Modulation of Epigenetic Effect in Alzheimer's Disease via Natural Compounds\u003cbr\u003e4. Energetic Crisis, Mitochondrial Vulnerability and Disruption of Lactate Shuttle in Alzheimer's Disease\u003cbr\u003e5. Astroglial Dysregulation and Gliotransmitter Imbalance in Schizophrenia\u003cbr\u003e6. Metabolic Disorders and Parkinson's Disease\u003cbr\u003e7. Molecular Insights of PPAR-γ Signalling in Amyotrophic Lateral Sclerosis and Huntington's Disease\u003cbr\u003e8. A Comprehensive Review on Therapeutics and Diagnostic Agents Targeting Acetyl and Butyryl Cholinesterases for AD\u003cbr\u003e9. Intestinal Microbiota in Neurodegeneration and Ageing\u003cbr\u003e10. Brain Energy Crisis in Alzheimer's and Parkinson's Disease: Can Nanocarriers Offer a Therapeutic Breakthrough?\u003cbr\u003e11. The Potential of HDAC Inhibitors for Alzheimer's Disease\u003cbr\u003e12. The Tau–Mitochondria Connection and Its Impact on Cellular Energy Metabolism in Alzheimer's Disease\u003cbr\u003e13. Brain Lipid Dysregulation as a Driver of Energy Metabolism Failure in Alzheimer's Disease\u003cbr\u003e14. Metabolic Dysregulation in Alzheimer's Disease: Mechanisms, Markers, and Therapeutic Prospects\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eWhy buy this book?\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003ePart of the established International Review of Neurobiology series, this volume gives researchers and clinicians a single, current reference on the metabolic dimension of Alzheimer's disease, tracing mitochondrial dysfunction, tau-metabolism links, and emerging nanocarrier and HDAC-inhibitor therapies alongside comparisons with Parkinson's disease and ALS. It's a strong addition to neuroscience and neurodegeneration research collections.\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eKeywords\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eBrain energy metabolism, Alzheimer's disease, neurodegenerative disease, mitochondrial dysfunction, tau pathology, Parkinson's disease, metabolic therapeutic targets, International Review of Neurobiology\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eUndergraduates, graduates, academics, and researchers in neurology and neurobiology, academic medical libraries\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eGenre\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003eNeurodegenerative Disease, Neurology\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003eQ\u0026amp;A\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWhere can I buy Brain Energy Metabolism in Alzheimer's Disease – Part C?\u003c\/strong\u003e\u003cbr\u003eYou can order it directly from CLNZ Books, with worldwide shipping and payment by card, PayPal, or bank transfer.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWhat is the International Review of Neurobiology series?\u003c\/strong\u003e\u003cbr\u003eIt's an established Elsevier book series presenting current research reviews across neuroscience and neurobiology; this is Volume 188, Part C on brain energy metabolism in Alzheimer's disease.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDoes this volume compare Alzheimer's with other neurodegenerative diseases?\u003c\/strong\u003e\u003cbr\u003eYes — chapters compare metabolic changes in Alzheimer's disease with Parkinson's disease, ALS, Huntington's disease and schizophrenia.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eDoes the volume cover emerging therapies?\u003c\/strong\u003e\u003cbr\u003eYes, including nanocarrier-based therapeutic approaches and HDAC inhibitors as emerging treatment strategies for Alzheimer's disease.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWho edited this volume?\u003c\/strong\u003e\u003cbr\u003eSubashchandrabose Chinnathambi, Additional Professor at the Department of Neurochemistry, National Institute of Mental Health and Neurosciences Hospital Bangalore, India.\u003c\/p\u003e\u003ch3\u003e\u003cstrong\u003e📘 Learn more about shipping, delivery times, and returns, see our FAQ here\u003c\/strong\u003e\u003c\/h3\u003e\u003cp\u003e\u003ca href=\"https:\/\/clnzbooks.com\/pages\/faq-frequently-asked-questions\" style=\"color:#8B0000;\"\u003eFAQ\u003c\/a\u003e\u003c\/p\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":44087382868042,"sku":"9780443345258","price":330.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0287\/7351\/5338\/files\/Neurobiology_2_89445c7c-29e7-4716-8cbb-6ca2c3b15dcc.jpg?v=1787178625","url":"https:\/\/clnzbooks.com\/products\/brain-energy-metabolism-alzheimers-c","provider":"CLNZ Books ","version":"1.0","type":"link"}